Crowdonomics
WatchlistPortfolio
All companies
NovaXS Biotech Corp. logo

NovaXS Biotech Corp.

Operating

NovaXS Biotech Corp

Biotech · Biotech · Trabuco Canyon, CA · Founded 2021

Woman-founded
Visit website

Needle-free self-injection technology | Ease of use, panless, better care

Valuation cap ⓘ
$14.0M
As of Feb 2023 · from Reg CF Offering (2022) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$1,338,555
Crowd $114K · Private $1.2M · 3 rounds since 2021

Financials

FY2020–FY2022 · from SEC filings · hover any figure for its source
$0
2020
$0
−$62K
2021
$0
−$441K
2022
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 reviewed*
FY2021 unaudited
FY2022 unaudited
Income statement
Revenue
$0
$0
$0
Cost of goods sold
$0
$0
$0
Net income
$0
-$62,494
-$441,043
Taxes paid
$0
$0
$656
Balance sheet
Cash
$0
$297,216
$281,066
Accounts receivable
$0
$0
$0
Total assets
$0
$297,216
$667,325
Short-term debt
$0
$7,872
$26,880
Long-term debt
$0
$290,000
$1,043,593
Total liabilities
$0
$297,872
$1,070,474
Other
Headcount
—
5
0

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$14.0M
Valuation cap
Reg CF · SAFE · Dec 2022

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · SAFE · Dec 2022Closedvia Republic
Raised $114.2K / $1.2MInvestors 231Valuation cap $14M
Section 4(a)(2) · Convertible Note · Mar 2022Closed
Raised $18.8K

Team

2 people
Alina Rui Su
CEO
Jonathan Tianyi Xing
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 4 annual reports (FY2022–FY2025)

231 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-TRMay 4, 20230001946145-23-000001
    EDGAR
  • Form C-ARApr 27, 20230001842944-23-000002
    EDGAR
  • Form C-UFeb 15, 20230001917224-23-000002
    EDGAR
  • Form CDec 5, 20220001946145-22-000001
    EDGAR
Source: ManualCIK 0001946145DE

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.